Gastro-Intestinal

THERAPEUTIC FIELDS

GASTRO-INTESTINAL


Gi Intolerance Can Affect Patient Outcomes

Feeding patients who are malnourished or at risk of malnutrition, whether by oral or enteral routes, can be a challenge since not all formulas are well tolerated. This can result in elevated gastric residuals, vomiting, diarrhoea, malab- sorption and/or abdominal pain.

The side effects resulting from GI intolerance have an impact on patient care.

ENTERAL NUTRITION IS BETTER FOR PATIENTS THAN PARENTERAL NUTRITION

The use of EN promotes intestinal trophism, stimulates insulin secretion and the immune system, and reduces the incidence of bacterial translocation and sepsis. Additional benefits of EN is reduced episode of hyperglycemia and reduced risk of liver dysfunction.5, 9, 10
Furthermore, EN is associated with fewer complications and costs less than PN.

PATIENTS IN THE INTENSIVE CARE UNIT

The prevalence of both acute and chronic malnutrition in critically ill children and adults is well documented. Early enteral nutrition is generally accepted as the standard of care for most hospitalised patients; however, delayed feeding still occurs with relative frequency. Early enteral nutrition is associated with decreased overall length of hospital stay in adult trauma, surgical and medical ICU patients.1-3,10,15




Barriers to optimal enteral nutrition to meet patients’ nutritional goals include lack of enteral access, vasoactive medications, neuromuscular blocking medications, fluid restriction, feeding intolerance (such as elevated gastric residuals, vomiting, constipation, diarrhoea and abdominal distension) and interruption of feeds due to procedures.5,17,18

WE HAVE THE ATTRIBUTES

  • Feed the gut and feed the patient: The first and only enzymatically hydrolysed 100% whey protein formula; high amount of MCT; balanced peptide profile. Designed for improved tolerance & absorption, providing optimal nutritional support and supporting optimal growth and development in children.
  • Tried and tested: Feeds the gut to make even the most difficult patients thrive and grow, built on evidence and experience (60 clinical studies, 23+ years of successful clinical experience, preferred by dieticians in the US).
  • Practical tools and services: Offering tools like ‘optimising the ICU ecosystem’s performance with Nx’ training sessions and new healthcare protocols, like PEP UP.
  • Proven return on investment: Reducing the cost of care associated with GI intolerance.
  • Use at home: For exclusive enteral nutrition to manage certain GI conditions, or to help patients adapt to solid food again during recovery.